ropivacaine has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashiguchi, S; Katori, N; Kosugi, S; Morisaki, H; Nishimura, D; Seki, H; Suzuki, T | 1 |
| Li, Y; Yan, M; Zhu, S | 1 |
1 trial(s) available for ropivacaine and Cancer of Kidney
| Article | Year |
|---|---|
Combined general/epidural anesthesia (ropivacaine 0.375%) versus general anesthesia for upper abdominal surgery.
Topics: Abdomen; Adult; Amides; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Blood Glucose; Blood Pressure; Epinephrine; Female; Heart Rate; Humans; Hydrocortisone; Kidney Neoplasms; Male; Middle Aged; Monitoring, Intraoperative; Nephrectomy; Perioperative Care; Propofol; Prospective Studies; Ropivacaine; Sufentanil; Time Factors | 2008 |
1 other study(ies) available for ropivacaine and Cancer of Kidney
| Article | Year |
|---|---|
Neurolysis targeting both the aorticorenal ganglia and lumbar sympathetic plexus for kidney tumor-related pain.
Topics: Adult; Amides; Anesthetics, Local; Ganglia, Sympathetic; Humans; Kidney Neoplasms; Lumbosacral Plexus; Male; Nerve Block; Pain; Ropivacaine; Sarcoma; Soft Tissue Neoplasms | 2015 |